nodes	percent_of_prediction	percent_of_DWPC	metapath
Mepenzolate—Urinary retention—Niacin—atherosclerosis	0.014	0.0216	CcSEcCtD
Mepenzolate—Erectile dysfunction—Lovastatin—atherosclerosis	0.0137	0.021	CcSEcCtD
Mepenzolate—Erectile dysfunction—Ezetimibe—atherosclerosis	0.0134	0.0206	CcSEcCtD
Mepenzolate—Abdominal distension—Niacin—atherosclerosis	0.0128	0.0198	CcSEcCtD
Mepenzolate—Erectile dysfunction—Simvastatin—atherosclerosis	0.0128	0.0197	CcSEcCtD
Mepenzolate—Abdominal distension—Pravastatin—atherosclerosis	0.0126	0.0194	CcSEcCtD
Mepenzolate—Erectile dysfunction—Niacin—atherosclerosis	0.0117	0.0181	CcSEcCtD
Mepenzolate—Erectile dysfunction—Pravastatin—atherosclerosis	0.0116	0.0178	CcSEcCtD
Mepenzolate—Clemastine—HRH1—atherosclerosis	0.011	0.21	CrCbGaD
Mepenzolate—Clofedanol—HRH1—atherosclerosis	0.0104	0.199	CrCbGaD
Mepenzolate—Confusional state—Rosuvastatin—atherosclerosis	0.01	0.0155	CcSEcCtD
Mepenzolate—Vision blurred—Lovastatin—atherosclerosis	0.00974	0.015	CcSEcCtD
Mepenzolate—Vision blurred—Simvastatin—atherosclerosis	0.00911	0.014	CcSEcCtD
Mepenzolate—Diphenylpyraline—HRH1—atherosclerosis	0.00905	0.173	CrCbGaD
Mepenzolate—Insomnia—Rosuvastatin—atherosclerosis	0.00901	0.0139	CcSEcCtD
Mepenzolate—Palpitations—Ezetimibe—atherosclerosis	0.00896	0.0138	CcSEcCtD
Mepenzolate—Tension—Niacin—atherosclerosis	0.00871	0.0134	CcSEcCtD
Mepenzolate—Nervousness—Niacin—atherosclerosis	0.00863	0.0133	CcSEcCtD
Mepenzolate—Dry mouth—Lovastatin—atherosclerosis	0.00861	0.0133	CcSEcCtD
Mepenzolate—Tension—Pravastatin—atherosclerosis	0.00858	0.0132	CcSEcCtD
Mepenzolate—Constipation—Rosuvastatin—atherosclerosis	0.00852	0.0131	CcSEcCtD
Mepenzolate—Confusional state—Lovastatin—atherosclerosis	0.00851	0.0131	CcSEcCtD
Mepenzolate—Nervousness—Pravastatin—atherosclerosis	0.00849	0.0131	CcSEcCtD
Mepenzolate—Dry mouth—Ezetimibe—atherosclerosis	0.00844	0.013	CcSEcCtD
Mepenzolate—Anaphylactic shock—Lovastatin—atherosclerosis	0.00844	0.013	CcSEcCtD
Mepenzolate—Vision blurred—Niacin—atherosclerosis	0.00837	0.0129	CcSEcCtD
Mepenzolate—Confusional state—Ezetimibe—atherosclerosis	0.00835	0.0128	CcSEcCtD
Mepenzolate—Anaphylactic shock—Ezetimibe—atherosclerosis	0.00828	0.0127	CcSEcCtD
Mepenzolate—Vision blurred—Pravastatin—atherosclerosis	0.00824	0.0127	CcSEcCtD
Mepenzolate—Feeling abnormal—Rosuvastatin—atherosclerosis	0.00821	0.0126	CcSEcCtD
Mepenzolate—Confusional state—Simvastatin—atherosclerosis	0.00796	0.0123	CcSEcCtD
Mepenzolate—Urticaria—Rosuvastatin—atherosclerosis	0.00791	0.0122	CcSEcCtD
Mepenzolate—Anaphylactic shock—Simvastatin—atherosclerosis	0.00789	0.0122	CcSEcCtD
Mepenzolate—Palpitations—Niacin—atherosclerosis	0.00785	0.0121	CcSEcCtD
Mepenzolate—Insomnia—Lovastatin—atherosclerosis	0.00763	0.0117	CcSEcCtD
Mepenzolate—Fexofenadine—HRH1—atherosclerosis	0.00761	0.146	CrCbGaD
Mepenzolate—Insomnia—Ezetimibe—atherosclerosis	0.00749	0.0115	CcSEcCtD
Mepenzolate—Dry mouth—Niacin—atherosclerosis	0.00739	0.0114	CcSEcCtD
Mepenzolate—Hypersensitivity—Rosuvastatin—atherosclerosis	0.00734	0.0113	CcSEcCtD
Mepenzolate—Cyclizine—HRH1—atherosclerosis	0.00728	0.139	CrCbGaD
Mepenzolate—Anaphylactic shock—Niacin—atherosclerosis	0.00725	0.0112	CcSEcCtD
Mepenzolate—Constipation—Lovastatin—atherosclerosis	0.00722	0.0111	CcSEcCtD
Mepenzolate—Confusional state—Pravastatin—atherosclerosis	0.0072	0.0111	CcSEcCtD
Mepenzolate—Asthenia—Rosuvastatin—atherosclerosis	0.00714	0.011	CcSEcCtD
Mepenzolate—Insomnia—Simvastatin—atherosclerosis	0.00714	0.011	CcSEcCtD
Mepenzolate—Anaphylactic shock—Pravastatin—atherosclerosis	0.00714	0.011	CcSEcCtD
Mepenzolate—Constipation—Ezetimibe—atherosclerosis	0.00708	0.0109	CcSEcCtD
Mepenzolate—Tachycardia—Niacin—atherosclerosis	0.00707	0.0109	CcSEcCtD
Mepenzolate—Feeling abnormal—Lovastatin—atherosclerosis	0.00695	0.0107	CcSEcCtD
Mepenzolate—Benzatropine—HRH1—atherosclerosis	0.00694	0.133	CrCbGaD
Mepenzolate—Feeling abnormal—Ezetimibe—atherosclerosis	0.00682	0.0105	CcSEcCtD
Mepenzolate—Constipation—Simvastatin—atherosclerosis	0.00675	0.0104	CcSEcCtD
Mepenzolate—Urticaria—Lovastatin—atherosclerosis	0.0067	0.0103	CcSEcCtD
Mepenzolate—Dizziness—Rosuvastatin—atherosclerosis	0.00658	0.0101	CcSEcCtD
Mepenzolate—Urticaria—Ezetimibe—atherosclerosis	0.00658	0.0101	CcSEcCtD
Mepenzolate—Insomnia—Niacin—atherosclerosis	0.00656	0.0101	CcSEcCtD
Mepenzolate—Feeling abnormal—Simvastatin—atherosclerosis	0.0065	0.01	CcSEcCtD
Mepenzolate—Insomnia—Pravastatin—atherosclerosis	0.00645	0.00994	CcSEcCtD
Mepenzolate—Somnolence—Niacin—atherosclerosis	0.00644	0.00992	CcSEcCtD
Mepenzolate—Urticaria—Simvastatin—atherosclerosis	0.00627	0.00965	CcSEcCtD
Mepenzolate—Headache—Rosuvastatin—atherosclerosis	0.00624	0.0096	CcSEcCtD
Mepenzolate—Hypersensitivity—Lovastatin—atherosclerosis	0.00622	0.00957	CcSEcCtD
Mepenzolate—Constipation—Pravastatin—atherosclerosis	0.0061	0.00939	CcSEcCtD
Mepenzolate—Hypersensitivity—Ezetimibe—atherosclerosis	0.0061	0.00939	CcSEcCtD
Mepenzolate—Asthenia—Lovastatin—atherosclerosis	0.00605	0.00932	CcSEcCtD
Mepenzolate—Asthenia—Ezetimibe—atherosclerosis	0.00594	0.00914	CcSEcCtD
Mepenzolate—Nausea—Rosuvastatin—atherosclerosis	0.00591	0.0091	CcSEcCtD
Mepenzolate—Feeling abnormal—Pravastatin—atherosclerosis	0.00588	0.00905	CcSEcCtD
Mepenzolate—Hypersensitivity—Simvastatin—atherosclerosis	0.00582	0.00895	CcSEcCtD
Mepenzolate—Urticaria—Niacin—atherosclerosis	0.00576	0.00886	CcSEcCtD
Mepenzolate—Urticaria—Pravastatin—atherosclerosis	0.00567	0.00873	CcSEcCtD
Mepenzolate—Asthenia—Simvastatin—atherosclerosis	0.00566	0.00872	CcSEcCtD
Mepenzolate—Dizziness—Lovastatin—atherosclerosis	0.00558	0.00859	CcSEcCtD
Mepenzolate—Dizziness—Ezetimibe—atherosclerosis	0.00547	0.00843	CcSEcCtD
Mepenzolate—Vomiting—Lovastatin—atherosclerosis	0.00537	0.00826	CcSEcCtD
Mepenzolate—Hypersensitivity—Niacin—atherosclerosis	0.00534	0.00822	CcSEcCtD
Mepenzolate—Headache—Lovastatin—atherosclerosis	0.00529	0.00814	CcSEcCtD
Mepenzolate—Vomiting—Ezetimibe—atherosclerosis	0.00526	0.0081	CcSEcCtD
Mepenzolate—Hypersensitivity—Pravastatin—atherosclerosis	0.00526	0.00809	CcSEcCtD
Mepenzolate—Dizziness—Simvastatin—atherosclerosis	0.00522	0.00803	CcSEcCtD
Mepenzolate—Asthenia—Niacin—atherosclerosis	0.0052	0.008	CcSEcCtD
Mepenzolate—Headache—Ezetimibe—atherosclerosis	0.00519	0.00798	CcSEcCtD
Mepenzolate—Asthenia—Pravastatin—atherosclerosis	0.00512	0.00788	CcSEcCtD
Mepenzolate—Vomiting—Simvastatin—atherosclerosis	0.00502	0.00773	CcSEcCtD
Mepenzolate—Nausea—Lovastatin—atherosclerosis	0.00501	0.00772	CcSEcCtD
Mepenzolate—Headache—Simvastatin—atherosclerosis	0.00494	0.00761	CcSEcCtD
Mepenzolate—Nausea—Ezetimibe—atherosclerosis	0.00492	0.00757	CcSEcCtD
Mepenzolate—Dizziness—Niacin—atherosclerosis	0.00479	0.00738	CcSEcCtD
Mepenzolate—Dizziness—Pravastatin—atherosclerosis	0.00472	0.00726	CcSEcCtD
Mepenzolate—Nausea—Simvastatin—atherosclerosis	0.00469	0.00722	CcSEcCtD
Mepenzolate—Vomiting—Niacin—atherosclerosis	0.00461	0.00709	CcSEcCtD
Mepenzolate—Headache—Niacin—atherosclerosis	0.00454	0.00699	CcSEcCtD
Mepenzolate—Vomiting—Pravastatin—atherosclerosis	0.00454	0.00698	CcSEcCtD
Mepenzolate—Headache—Pravastatin—atherosclerosis	0.00447	0.00688	CcSEcCtD
Mepenzolate—Nausea—Niacin—atherosclerosis	0.00431	0.00663	CcSEcCtD
Mepenzolate—Nausea—Pravastatin—atherosclerosis	0.00424	0.00652	CcSEcCtD
Mepenzolate—CHRM3—Signaling by GPCR—AGTR1—atherosclerosis	0.000229	0.000769	CbGpPWpGaD
Mepenzolate—CHRM2—Signaling by GPCR—KNG1—atherosclerosis	0.000228	0.000766	CbGpPWpGaD
Mepenzolate—CHRM2—Signaling Pathways—UTS2—atherosclerosis	0.000228	0.000764	CbGpPWpGaD
Mepenzolate—CHRM2—Signaling by GPCR—AGTR1—atherosclerosis	0.000227	0.000762	CbGpPWpGaD
Mepenzolate—CHRM1—Signaling Pathways—CX3CR1—atherosclerosis	0.000221	0.000742	CbGpPWpGaD
Mepenzolate—CHRM1—Signaling Pathways—CASR—atherosclerosis	0.000221	0.000742	CbGpPWpGaD
Mepenzolate—CHRM3—Signaling Pathways—CX3CR1—atherosclerosis	0.00022	0.000739	CbGpPWpGaD
Mepenzolate—CHRM3—Signaling Pathways—CASR—atherosclerosis	0.00022	0.000739	CbGpPWpGaD
Mepenzolate—CHRM3—Metabolism—NAMPT—atherosclerosis	0.00022	0.000737	CbGpPWpGaD
Mepenzolate—CHRM3—Metabolism—LIPC—atherosclerosis	0.000218	0.000733	CbGpPWpGaD
Mepenzolate—CHRM2—Signaling Pathways—CX3CR1—atherosclerosis	0.000218	0.000732	CbGpPWpGaD
Mepenzolate—CHRM2—Signaling Pathways—CASR—atherosclerosis	0.000218	0.000732	CbGpPWpGaD
Mepenzolate—CHRM3—Metabolism—APOC3—atherosclerosis	0.000217	0.000728	CbGpPWpGaD
Mepenzolate—CHRM1—Signaling Pathways—CX3CL1—atherosclerosis	0.000217	0.000727	CbGpPWpGaD
Mepenzolate—CHRM3—Signaling Pathways—CX3CL1—atherosclerosis	0.000216	0.000725	CbGpPWpGaD
Mepenzolate—CHRM1—Circadian rythm related genes—IL6—atherosclerosis	0.000216	0.000724	CbGpPWpGaD
Mepenzolate—CHRM3—Metabolism—LDLR—atherosclerosis	0.000216	0.000724	CbGpPWpGaD
Mepenzolate—CHRM1—GPCR downstream signaling—EDN1—atherosclerosis	0.000215	0.00072	CbGpPWpGaD
Mepenzolate—CHRM3—GPCR downstream signaling—EDN1—atherosclerosis	0.000214	0.000718	CbGpPWpGaD
Mepenzolate—CHRM2—Signaling Pathways—CX3CL1—atherosclerosis	0.000214	0.000718	CbGpPWpGaD
Mepenzolate—CHRM1—GPCR downstream signaling—CCL5—atherosclerosis	0.000213	0.000715	CbGpPWpGaD
Mepenzolate—CHRM3—GPCR downstream signaling—CCL5—atherosclerosis	0.000212	0.000713	CbGpPWpGaD
Mepenzolate—CHRM2—GPCR downstream signaling—EDN1—atherosclerosis	0.000212	0.000711	CbGpPWpGaD
Mepenzolate—CHRM3—Metabolism—CETP—atherosclerosis	0.000211	0.000707	CbGpPWpGaD
Mepenzolate—CHRM2—GPCR downstream signaling—CCL5—atherosclerosis	0.00021	0.000706	CbGpPWpGaD
Mepenzolate—CHRM1—Signaling Pathways—CNR2—atherosclerosis	0.000206	0.000689	CbGpPWpGaD
Mepenzolate—CHRM1—GPCR ligand binding—CXCL8—atherosclerosis	0.000205	0.000689	CbGpPWpGaD
Mepenzolate—CHRM1—Signaling by GPCR—MMP3—atherosclerosis	0.000205	0.000688	CbGpPWpGaD
Mepenzolate—CHRM3—Signaling Pathways—CNR2—atherosclerosis	0.000205	0.000687	CbGpPWpGaD
Mepenzolate—CHRM3—GPCR ligand binding—CXCL8—atherosclerosis	0.000205	0.000687	CbGpPWpGaD
Mepenzolate—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—atherosclerosis	0.000205	0.000686	CbGpPWpGaD
Mepenzolate—CHRM3—Signaling by GPCR—MMP3—atherosclerosis	0.000204	0.000686	CbGpPWpGaD
Mepenzolate—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—atherosclerosis	0.000204	0.000684	CbGpPWpGaD
Mepenzolate—CHRM2—Signaling Pathways—CNR2—atherosclerosis	0.000203	0.000681	CbGpPWpGaD
Mepenzolate—CHRM2—GPCR ligand binding—CXCL8—atherosclerosis	0.000203	0.00068	CbGpPWpGaD
Mepenzolate—CHRM1—GPCR downstream signaling—PRKCG—atherosclerosis	0.000203	0.00068	CbGpPWpGaD
Mepenzolate—CHRM2—Signaling by GPCR—MMP3—atherosclerosis	0.000202	0.000679	CbGpPWpGaD
Mepenzolate—CHRM3—GPCR downstream signaling—PRKCG—atherosclerosis	0.000202	0.000677	CbGpPWpGaD
Mepenzolate—CHRM3—Metabolism—SCARB1—atherosclerosis	0.000202	0.000677	CbGpPWpGaD
Mepenzolate—CHRM2—GPCR downstream signaling—PRKCG—atherosclerosis	0.0002	0.000671	CbGpPWpGaD
Mepenzolate—CHRM1—Signaling by GPCR—EDN1—atherosclerosis	0.000195	0.000654	CbGpPWpGaD
Mepenzolate—CHRM3—Signaling by GPCR—EDN1—atherosclerosis	0.000194	0.000652	CbGpPWpGaD
Mepenzolate—CHRM1—Signaling by GPCR—CCL5—atherosclerosis	0.000194	0.000649	CbGpPWpGaD
Mepenzolate—CHRM3—Signaling by GPCR—CCL5—atherosclerosis	0.000193	0.000647	CbGpPWpGaD
Mepenzolate—CHRM2—Signaling by GPCR—EDN1—atherosclerosis	0.000193	0.000646	CbGpPWpGaD
Mepenzolate—CHRM2—Signaling by GPCR—CCL5—atherosclerosis	0.000191	0.000641	CbGpPWpGaD
Mepenzolate—CHRM3—Metabolism—HMGCR—atherosclerosis	0.000191	0.000639	CbGpPWpGaD
Mepenzolate—CHRM1—Signaling by GPCR—PRKCG—atherosclerosis	0.000184	0.000617	CbGpPWpGaD
Mepenzolate—CHRM3—Signaling by GPCR—PRKCG—atherosclerosis	0.000183	0.000615	CbGpPWpGaD
Mepenzolate—CHRM1—Signaling Pathways—VWF—atherosclerosis	0.000183	0.000614	CbGpPWpGaD
Mepenzolate—CHRM3—Signaling Pathways—VWF—atherosclerosis	0.000183	0.000613	CbGpPWpGaD
Mepenzolate—CHRM1—Signaling Pathways—APOC3—atherosclerosis	0.000182	0.000611	CbGpPWpGaD
Mepenzolate—CHRM2—Signaling by GPCR—PRKCG—atherosclerosis	0.000182	0.000609	CbGpPWpGaD
Mepenzolate—CHRM3—Signaling Pathways—APOC3—atherosclerosis	0.000181	0.000609	CbGpPWpGaD
Mepenzolate—CHRM1—Signaling Pathways—LDLR—atherosclerosis	0.000181	0.000607	CbGpPWpGaD
Mepenzolate—CHRM2—Signaling Pathways—VWF—atherosclerosis	0.000181	0.000607	CbGpPWpGaD
Mepenzolate—CHRM3—Signaling Pathways—LDLR—atherosclerosis	0.00018	0.000605	CbGpPWpGaD
Mepenzolate—CHRM2—Signaling Pathways—APOC3—atherosclerosis	0.00018	0.000603	CbGpPWpGaD
Mepenzolate—CHRM2—Signaling Pathways—LDLR—atherosclerosis	0.000179	0.000599	CbGpPWpGaD
Mepenzolate—CHRM1—GPCR downstream signaling—AGT—atherosclerosis	0.000178	0.000598	CbGpPWpGaD
Mepenzolate—CHRM3—GPCR downstream signaling—AGT—atherosclerosis	0.000178	0.000596	CbGpPWpGaD
Mepenzolate—CHRM1—Signaling Pathways—CCL3—atherosclerosis	0.000177	0.000593	CbGpPWpGaD
Mepenzolate—CHRM3—Signaling Pathways—CCL3—atherosclerosis	0.000176	0.000591	CbGpPWpGaD
Mepenzolate—CHRM2—GPCR downstream signaling—AGT—atherosclerosis	0.000176	0.00059	CbGpPWpGaD
Mepenzolate—CHRM2—Signaling Pathways—CCL3—atherosclerosis	0.000174	0.000585	CbGpPWpGaD
Mepenzolate—CHRM3—Metabolism—ABCA1—atherosclerosis	0.00017	0.00057	CbGpPWpGaD
Mepenzolate—CHRM1—Signaling Pathways—NCF1—atherosclerosis	0.000169	0.000568	CbGpPWpGaD
Mepenzolate—CHRM3—Signaling Pathways—NCF1—atherosclerosis	0.000169	0.000566	CbGpPWpGaD
Mepenzolate—CHRM2—Signaling Pathways—NCF1—atherosclerosis	0.000167	0.00056	CbGpPWpGaD
Mepenzolate—CHRM1—GPCR downstream signaling—F2—atherosclerosis	0.000165	0.000553	CbGpPWpGaD
Mepenzolate—CHRM3—GPCR downstream signaling—F2—atherosclerosis	0.000164	0.000551	CbGpPWpGaD
Mepenzolate—CHRM2—GPCR downstream signaling—F2—atherosclerosis	0.000163	0.000545	CbGpPWpGaD
Mepenzolate—CHRM1—Signaling by GPCR—AGT—atherosclerosis	0.000162	0.000543	CbGpPWpGaD
Mepenzolate—CHRM3—Signaling by GPCR—AGT—atherosclerosis	0.000161	0.000541	CbGpPWpGaD
Mepenzolate—CHRM1—Signaling Pathways—EDNRA—atherosclerosis	0.00016	0.000536	CbGpPWpGaD
Mepenzolate—CHRM1—Signaling Pathways—CCR2—atherosclerosis	0.00016	0.000536	CbGpPWpGaD
Mepenzolate—CHRM2—Signaling by GPCR—AGT—atherosclerosis	0.00016	0.000536	CbGpPWpGaD
Mepenzolate—CHRM3—Signaling Pathways—EDNRA—atherosclerosis	0.000159	0.000534	CbGpPWpGaD
Mepenzolate—CHRM3—Signaling Pathways—CCR2—atherosclerosis	0.000159	0.000534	CbGpPWpGaD
Mepenzolate—CHRM1—Signaling Pathways—CYBA—atherosclerosis	0.000159	0.000534	CbGpPWpGaD
Mepenzolate—CHRM3—Signaling Pathways—CYBA—atherosclerosis	0.000159	0.000532	CbGpPWpGaD
Mepenzolate—CHRM2—Signaling Pathways—EDNRA—atherosclerosis	0.000158	0.000529	CbGpPWpGaD
Mepenzolate—CHRM2—Signaling Pathways—CCR2—atherosclerosis	0.000158	0.000529	CbGpPWpGaD
Mepenzolate—CHRM1—GPCR downstream signaling—PIK3CG—atherosclerosis	0.000158	0.000529	CbGpPWpGaD
Mepenzolate—CHRM3—GPCR downstream signaling—PIK3CG—atherosclerosis	0.000157	0.000527	CbGpPWpGaD
Mepenzolate—CHRM2—Signaling Pathways—CYBA—atherosclerosis	0.000157	0.000527	CbGpPWpGaD
Mepenzolate—CHRM1—Signaling Pathways—GHRL—atherosclerosis	0.000156	0.000522	CbGpPWpGaD
Mepenzolate—CHRM1—Signaling Pathways—PARP1—atherosclerosis	0.000156	0.000522	CbGpPWpGaD
Mepenzolate—CHRM1—Signaling Pathways—PLAT—atherosclerosis	0.000156	0.000522	CbGpPWpGaD
Mepenzolate—CHRM2—GPCR downstream signaling—PIK3CG—atherosclerosis	0.000156	0.000522	CbGpPWpGaD
Mepenzolate—CHRM3—Signaling Pathways—PLAT—atherosclerosis	0.000155	0.000521	CbGpPWpGaD
Mepenzolate—CHRM3—Signaling Pathways—PARP1—atherosclerosis	0.000155	0.000521	CbGpPWpGaD
Mepenzolate—CHRM3—Signaling Pathways—GHRL—atherosclerosis	0.000155	0.000521	CbGpPWpGaD
Mepenzolate—CHRM2—Signaling Pathways—PLAT—atherosclerosis	0.000154	0.000516	CbGpPWpGaD
Mepenzolate—CHRM2—Signaling Pathways—PARP1—atherosclerosis	0.000154	0.000516	CbGpPWpGaD
Mepenzolate—CHRM2—Signaling Pathways—GHRL—atherosclerosis	0.000154	0.000516	CbGpPWpGaD
Mepenzolate—CHRM1—Signaling by GPCR—F2—atherosclerosis	0.00015	0.000502	CbGpPWpGaD
Mepenzolate—CHRM3—Signaling by GPCR—F2—atherosclerosis	0.000149	0.0005	CbGpPWpGaD
Mepenzolate—CHRM2—Signaling by GPCR—F2—atherosclerosis	0.000148	0.000495	CbGpPWpGaD
Mepenzolate—CHRM3—Metabolism—HMOX1—atherosclerosis	0.000146	0.000489	CbGpPWpGaD
Mepenzolate—CHRM1—Signaling by GPCR—PIK3CG—atherosclerosis	0.000143	0.00048	CbGpPWpGaD
Mepenzolate—CHRM3—Signaling by GPCR—PIK3CG—atherosclerosis	0.000143	0.000479	CbGpPWpGaD
Mepenzolate—CHRM2—Signaling by GPCR—PIK3CG—atherosclerosis	0.000141	0.000474	CbGpPWpGaD
Mepenzolate—CHRM3—Metabolism—APOB—atherosclerosis	0.00014	0.000468	CbGpPWpGaD
Mepenzolate—CHRM1—Signaling Pathways—KNG1—atherosclerosis	0.000137	0.000459	CbGpPWpGaD
Mepenzolate—CHRM3—Signaling Pathways—KNG1—atherosclerosis	0.000136	0.000457	CbGpPWpGaD
Mepenzolate—CHRM1—Signaling Pathways—AGTR1—atherosclerosis	0.000136	0.000456	CbGpPWpGaD
Mepenzolate—CHRM3—Metabolism—GSTM1—atherosclerosis	0.000136	0.000455	CbGpPWpGaD
Mepenzolate—CHRM3—Signaling Pathways—AGTR1—atherosclerosis	0.000135	0.000454	CbGpPWpGaD
Mepenzolate—CHRM2—Signaling Pathways—KNG1—atherosclerosis	0.000135	0.000453	CbGpPWpGaD
Mepenzolate—CHRM2—Signaling Pathways—AGTR1—atherosclerosis	0.000134	0.00045	CbGpPWpGaD
Mepenzolate—CHRM1—Signaling by GPCR—CCL2—atherosclerosis	0.000133	0.000447	CbGpPWpGaD
Mepenzolate—CHRM3—Metabolism—LPL—atherosclerosis	0.000133	0.000447	CbGpPWpGaD
Mepenzolate—CHRM3—Signaling by GPCR—CCL2—atherosclerosis	0.000133	0.000446	CbGpPWpGaD
Mepenzolate—CHRM1—Signaling Pathways—PLG—atherosclerosis	0.000132	0.000444	CbGpPWpGaD
Mepenzolate—CHRM3—Signaling Pathways—PLG—atherosclerosis	0.000132	0.000443	CbGpPWpGaD
Mepenzolate—CHRM2—Signaling by GPCR—CCL2—atherosclerosis	0.000132	0.000441	CbGpPWpGaD
Mepenzolate—CHRM2—Signaling Pathways—PLG—atherosclerosis	0.000131	0.000439	CbGpPWpGaD
Mepenzolate—CHRM3—Metabolism—GPX1—atherosclerosis	0.00013	0.000436	CbGpPWpGaD
Mepenzolate—CHRM3—Metabolism—CD36—atherosclerosis	0.000127	0.000425	CbGpPWpGaD
Mepenzolate—CHRM1—Signaling Pathways—SOCS3—atherosclerosis	0.000125	0.000421	CbGpPWpGaD
Mepenzolate—CHRM3—Signaling Pathways—SOCS3—atherosclerosis	0.000125	0.000419	CbGpPWpGaD
Mepenzolate—CHRM2—Signaling Pathways—SOCS3—atherosclerosis	0.000124	0.000415	CbGpPWpGaD
Mepenzolate—CHRM1—Signaling Pathways—MMP3—atherosclerosis	0.000121	0.000406	CbGpPWpGaD
Mepenzolate—CHRM3—Signaling Pathways—MMP3—atherosclerosis	0.000121	0.000405	CbGpPWpGaD
Mepenzolate—CHRM1—Signaling Pathways—IGF2—atherosclerosis	0.000121	0.000405	CbGpPWpGaD
Mepenzolate—CHRM3—Signaling Pathways—IGF2—atherosclerosis	0.00012	0.000403	CbGpPWpGaD
Mepenzolate—CHRM3—Metabolism—MTHFR—atherosclerosis	0.00012	0.000402	CbGpPWpGaD
Mepenzolate—CHRM2—Signaling Pathways—MMP3—atherosclerosis	0.00012	0.000401	CbGpPWpGaD
Mepenzolate—CHRM2—Signaling Pathways—IGF2—atherosclerosis	0.000119	0.000399	CbGpPWpGaD
Mepenzolate—CHRM3—Metabolism—PPARA—atherosclerosis	0.000118	0.000395	CbGpPWpGaD
Mepenzolate—CHRM1—Signaling Pathways—APOB—atherosclerosis	0.000117	0.000393	CbGpPWpGaD
Mepenzolate—CHRM3—Signaling Pathways—APOB—atherosclerosis	0.000117	0.000391	CbGpPWpGaD
Mepenzolate—CHRM1—GPCR downstream signaling—CXCL8—atherosclerosis	0.000116	0.000389	CbGpPWpGaD
Mepenzolate—CHRM3—GPCR downstream signaling—CXCL8—atherosclerosis	0.000116	0.000388	CbGpPWpGaD
Mepenzolate—CHRM2—Signaling Pathways—APOB—atherosclerosis	0.000116	0.000388	CbGpPWpGaD
Mepenzolate—CHRM1—Signaling Pathways—EDN1—atherosclerosis	0.000115	0.000386	CbGpPWpGaD
Mepenzolate—CHRM3—Signaling Pathways—EDN1—atherosclerosis	0.000115	0.000385	CbGpPWpGaD
Mepenzolate—CHRM2—GPCR downstream signaling—CXCL8—atherosclerosis	0.000115	0.000384	CbGpPWpGaD
Mepenzolate—CHRM1—Signaling Pathways—CCL5—atherosclerosis	0.000114	0.000383	CbGpPWpGaD
Mepenzolate—CHRM3—Metabolism—AGT—atherosclerosis	0.000114	0.000382	CbGpPWpGaD
Mepenzolate—CHRM3—Signaling Pathways—CCL5—atherosclerosis	0.000114	0.000382	CbGpPWpGaD
Mepenzolate—CHRM2—Signaling Pathways—EDN1—atherosclerosis	0.000114	0.000382	CbGpPWpGaD
Mepenzolate—CHRM2—Signaling Pathways—CCL5—atherosclerosis	0.000113	0.000379	CbGpPWpGaD
Mepenzolate—CHRM1—Signaling Pathways—LPL—atherosclerosis	0.000112	0.000375	CbGpPWpGaD
Mepenzolate—CHRM3—Metabolism—APOE—atherosclerosis	0.000112	0.000375	CbGpPWpGaD
Mepenzolate—CHRM3—Signaling Pathways—LPL—atherosclerosis	0.000111	0.000374	CbGpPWpGaD
Mepenzolate—CHRM3—Metabolism—CAV1—atherosclerosis	0.000111	0.000371	CbGpPWpGaD
Mepenzolate—CHRM3—Metabolism—APOA1—atherosclerosis	0.00011	0.00037	CbGpPWpGaD
Mepenzolate—CHRM2—Signaling Pathways—LPL—atherosclerosis	0.00011	0.00037	CbGpPWpGaD
Mepenzolate—CHRM1—Signaling Pathways—PRKCG—atherosclerosis	0.000109	0.000365	CbGpPWpGaD
Mepenzolate—CHRM3—Signaling Pathways—PRKCG—atherosclerosis	0.000108	0.000363	CbGpPWpGaD
Mepenzolate—CHRM2—Signaling Pathways—PRKCG—atherosclerosis	0.000107	0.00036	CbGpPWpGaD
Mepenzolate—CHRM1—Signaling Pathways—SPP1—atherosclerosis	0.000106	0.000355	CbGpPWpGaD
Mepenzolate—CHRM3—Signaling Pathways—SPP1—atherosclerosis	0.000106	0.000354	CbGpPWpGaD
Mepenzolate—CHRM1—Signaling by GPCR—CXCL8—atherosclerosis	0.000105	0.000354	CbGpPWpGaD
Mepenzolate—CHRM3—Signaling by GPCR—CXCL8—atherosclerosis	0.000105	0.000352	CbGpPWpGaD
Mepenzolate—CHRM2—Signaling Pathways—SPP1—atherosclerosis	0.000105	0.000351	CbGpPWpGaD
Mepenzolate—CHRM2—Signaling by GPCR—CXCL8—atherosclerosis	0.000104	0.000349	CbGpPWpGaD
Mepenzolate—CHRM3—Metabolism—PIK3CG—atherosclerosis	0.000101	0.000338	CbGpPWpGaD
Mepenzolate—CHRM1—Signaling Pathways—PDGFB—atherosclerosis	9.8e-05	0.000329	CbGpPWpGaD
Mepenzolate—CHRM3—Signaling Pathways—PDGFB—atherosclerosis	9.76e-05	0.000328	CbGpPWpGaD
Mepenzolate—CHRM3—Metabolism—PPARG—atherosclerosis	9.73e-05	0.000326	CbGpPWpGaD
Mepenzolate—CHRM2—Signaling Pathways—PDGFB—atherosclerosis	9.67e-05	0.000324	CbGpPWpGaD
Mepenzolate—CHRM1—Signaling Pathways—AGT—atherosclerosis	9.56e-05	0.000321	CbGpPWpGaD
Mepenzolate—CHRM3—Metabolism—INS—atherosclerosis	9.54e-05	0.00032	CbGpPWpGaD
Mepenzolate—CHRM3—Signaling Pathways—AGT—atherosclerosis	9.53e-05	0.00032	CbGpPWpGaD
Mepenzolate—CHRM2—Signaling Pathways—AGT—atherosclerosis	9.44e-05	0.000317	CbGpPWpGaD
Mepenzolate—CHRM1—Signaling Pathways—LEP—atherosclerosis	9.37e-05	0.000314	CbGpPWpGaD
Mepenzolate—CHRM1—Signaling Pathways—APOE—atherosclerosis	9.37e-05	0.000314	CbGpPWpGaD
Mepenzolate—CHRM3—Signaling Pathways—LEP—atherosclerosis	9.34e-05	0.000313	CbGpPWpGaD
Mepenzolate—CHRM3—Signaling Pathways—APOE—atherosclerosis	9.34e-05	0.000313	CbGpPWpGaD
Mepenzolate—CHRM1—Signaling Pathways—CAV1—atherosclerosis	9.28e-05	0.000311	CbGpPWpGaD
Mepenzolate—CHRM1—Signaling Pathways—APOA1—atherosclerosis	9.26e-05	0.000311	CbGpPWpGaD
Mepenzolate—CHRM3—Signaling Pathways—CAV1—atherosclerosis	9.25e-05	0.00031	CbGpPWpGaD
Mepenzolate—CHRM2—Signaling Pathways—LEP—atherosclerosis	9.25e-05	0.00031	CbGpPWpGaD
Mepenzolate—CHRM2—Signaling Pathways—APOE—atherosclerosis	9.25e-05	0.00031	CbGpPWpGaD
Mepenzolate—CHRM3—Signaling Pathways—APOA1—atherosclerosis	9.23e-05	0.00031	CbGpPWpGaD
Mepenzolate—CHRM2—Signaling Pathways—CAV1—atherosclerosis	9.16e-05	0.000307	CbGpPWpGaD
Mepenzolate—CHRM2—Signaling Pathways—APOA1—atherosclerosis	9.14e-05	0.000307	CbGpPWpGaD
Mepenzolate—CHRM1—Signaling Pathways—ESR1—atherosclerosis	8.95e-05	0.0003	CbGpPWpGaD
Mepenzolate—CHRM3—Signaling Pathways—ESR1—atherosclerosis	8.92e-05	0.000299	CbGpPWpGaD
Mepenzolate—CHRM1—Signaling Pathways—F2—atherosclerosis	8.84e-05	0.000296	CbGpPWpGaD
Mepenzolate—CHRM2—Signaling Pathways—ESR1—atherosclerosis	8.83e-05	0.000296	CbGpPWpGaD
Mepenzolate—CHRM3—Signaling Pathways—F2—atherosclerosis	8.81e-05	0.000295	CbGpPWpGaD
Mepenzolate—CHRM3—Metabolism—ALB—atherosclerosis	8.75e-05	0.000293	CbGpPWpGaD
Mepenzolate—CHRM2—Signaling Pathways—F2—atherosclerosis	8.72e-05	0.000293	CbGpPWpGaD
Mepenzolate—CHRM1—Signaling Pathways—PIK3CG—atherosclerosis	8.46e-05	0.000284	CbGpPWpGaD
Mepenzolate—CHRM3—Signaling Pathways—PIK3CG—atherosclerosis	8.43e-05	0.000283	CbGpPWpGaD
Mepenzolate—CHRM3—Metabolism—NOS3—atherosclerosis	8.37e-05	0.000281	CbGpPWpGaD
Mepenzolate—CHRM2—Signaling Pathways—PIK3CG—atherosclerosis	8.35e-05	0.00028	CbGpPWpGaD
Mepenzolate—CHRM1—Signaling by GPCR—MAPK3—atherosclerosis	8.1e-05	0.000272	CbGpPWpGaD
Mepenzolate—CHRM3—Signaling by GPCR—MAPK3—atherosclerosis	8.07e-05	0.000271	CbGpPWpGaD
Mepenzolate—CHRM1—Signaling Pathways—INS—atherosclerosis	8e-05	0.000269	CbGpPWpGaD
Mepenzolate—CHRM2—Signaling by GPCR—MAPK3—atherosclerosis	7.99e-05	0.000268	CbGpPWpGaD
Mepenzolate—CHRM3—Signaling Pathways—INS—atherosclerosis	7.98e-05	0.000268	CbGpPWpGaD
Mepenzolate—CHRM2—Signaling Pathways—INS—atherosclerosis	7.9e-05	0.000265	CbGpPWpGaD
Mepenzolate—CHRM1—Signaling Pathways—CCL2—atherosclerosis	7.88e-05	0.000264	CbGpPWpGaD
Mepenzolate—CHRM3—Signaling Pathways—CCL2—atherosclerosis	7.85e-05	0.000263	CbGpPWpGaD
Mepenzolate—CHRM2—Signaling Pathways—CCL2—atherosclerosis	7.77e-05	0.000261	CbGpPWpGaD
Mepenzolate—CHRM1—Signaling Pathways—IGF1—atherosclerosis	7.74e-05	0.00026	CbGpPWpGaD
Mepenzolate—CHRM3—Signaling Pathways—IGF1—atherosclerosis	7.72e-05	0.000259	CbGpPWpGaD
Mepenzolate—CHRM3—Metabolism—PTGS2—atherosclerosis	7.65e-05	0.000257	CbGpPWpGaD
Mepenzolate—CHRM2—Signaling Pathways—IGF1—atherosclerosis	7.64e-05	0.000256	CbGpPWpGaD
Mepenzolate—CHRM1—Signaling Pathways—SERPINE1—atherosclerosis	7.35e-05	0.000247	CbGpPWpGaD
Mepenzolate—CHRM3—Signaling Pathways—SERPINE1—atherosclerosis	7.33e-05	0.000246	CbGpPWpGaD
Mepenzolate—CHRM2—Signaling Pathways—SERPINE1—atherosclerosis	7.26e-05	0.000243	CbGpPWpGaD
Mepenzolate—CHRM1—Signaling Pathways—NOS3—atherosclerosis	7.02e-05	0.000235	CbGpPWpGaD
Mepenzolate—CHRM3—Signaling Pathways—NOS3—atherosclerosis	7e-05	0.000235	CbGpPWpGaD
Mepenzolate—CHRM2—Signaling Pathways—NOS3—atherosclerosis	6.93e-05	0.000232	CbGpPWpGaD
Mepenzolate—CHRM1—Signaling Pathways—CXCL8—atherosclerosis	6.23e-05	0.000209	CbGpPWpGaD
Mepenzolate—CHRM3—Signaling Pathways—CXCL8—atherosclerosis	6.21e-05	0.000208	CbGpPWpGaD
Mepenzolate—CHRM2—Signaling Pathways—CXCL8—atherosclerosis	6.15e-05	0.000206	CbGpPWpGaD
Mepenzolate—CHRM1—GPCR downstream signaling—AKT1—atherosclerosis	6.01e-05	0.000202	CbGpPWpGaD
Mepenzolate—CHRM3—GPCR downstream signaling—AKT1—atherosclerosis	6e-05	0.000201	CbGpPWpGaD
Mepenzolate—CHRM2—GPCR downstream signaling—AKT1—atherosclerosis	5.94e-05	0.000199	CbGpPWpGaD
Mepenzolate—CHRM1—Signaling by GPCR—IL6—atherosclerosis	5.92e-05	0.000199	CbGpPWpGaD
Mepenzolate—CHRM3—Signaling by GPCR—IL6—atherosclerosis	5.9e-05	0.000198	CbGpPWpGaD
Mepenzolate—CHRM2—Signaling by GPCR—IL6—atherosclerosis	5.84e-05	0.000196	CbGpPWpGaD
Mepenzolate—CHRM1—Signaling Pathways—MMP9—atherosclerosis	5.63e-05	0.000189	CbGpPWpGaD
Mepenzolate—CHRM3—Signaling Pathways—MMP9—atherosclerosis	5.61e-05	0.000188	CbGpPWpGaD
Mepenzolate—CHRM1—Signaling Pathways—NFKB1—atherosclerosis	5.57e-05	0.000187	CbGpPWpGaD
Mepenzolate—CHRM2—Signaling Pathways—MMP9—atherosclerosis	5.56e-05	0.000186	CbGpPWpGaD
Mepenzolate—CHRM3—Signaling Pathways—NFKB1—atherosclerosis	5.55e-05	0.000186	CbGpPWpGaD
Mepenzolate—CHRM2—Signaling Pathways—NFKB1—atherosclerosis	5.5e-05	0.000185	CbGpPWpGaD
Mepenzolate—CHRM1—Signaling Pathways—MAPK8—atherosclerosis	5.48e-05	0.000184	CbGpPWpGaD
Mepenzolate—CHRM1—Signaling by GPCR—AKT1—atherosclerosis	5.46e-05	0.000183	CbGpPWpGaD
Mepenzolate—CHRM3—Signaling Pathways—MAPK8—atherosclerosis	5.46e-05	0.000183	CbGpPWpGaD
Mepenzolate—CHRM3—Signaling by GPCR—AKT1—atherosclerosis	5.44e-05	0.000183	CbGpPWpGaD
Mepenzolate—CHRM2—Signaling Pathways—MAPK8—atherosclerosis	5.41e-05	0.000181	CbGpPWpGaD
Mepenzolate—CHRM2—Signaling by GPCR—AKT1—atherosclerosis	5.39e-05	0.000181	CbGpPWpGaD
Mepenzolate—CHRM1—Signaling Pathways—VEGFA—atherosclerosis	5.06e-05	0.00017	CbGpPWpGaD
Mepenzolate—CHRM3—Signaling Pathways—VEGFA—atherosclerosis	5.04e-05	0.000169	CbGpPWpGaD
Mepenzolate—CHRM1—Signaling Pathways—STAT3—atherosclerosis	5.01e-05	0.000168	CbGpPWpGaD
Mepenzolate—CHRM2—Signaling Pathways—VEGFA—atherosclerosis	4.99e-05	0.000167	CbGpPWpGaD
Mepenzolate—CHRM3—Signaling Pathways—STAT3—atherosclerosis	4.99e-05	0.000167	CbGpPWpGaD
Mepenzolate—CHRM2—Signaling Pathways—STAT3—atherosclerosis	4.94e-05	0.000166	CbGpPWpGaD
Mepenzolate—CHRM1—Signaling Pathways—MAPK3—atherosclerosis	4.78e-05	0.00016	CbGpPWpGaD
Mepenzolate—CHRM3—Signaling Pathways—MAPK3—atherosclerosis	4.77e-05	0.00016	CbGpPWpGaD
Mepenzolate—CHRM2—Signaling Pathways—MAPK3—atherosclerosis	4.72e-05	0.000158	CbGpPWpGaD
Mepenzolate—CHRM1—Signaling Pathways—TGFB1—atherosclerosis	4.64e-05	0.000156	CbGpPWpGaD
Mepenzolate—CHRM3—Signaling Pathways—TGFB1—atherosclerosis	4.63e-05	0.000155	CbGpPWpGaD
Mepenzolate—CHRM2—Signaling Pathways—TGFB1—atherosclerosis	4.58e-05	0.000154	CbGpPWpGaD
Mepenzolate—CHRM3—Metabolism—AKT1—atherosclerosis	3.85e-05	0.000129	CbGpPWpGaD
Mepenzolate—CHRM1—Signaling Pathways—IL6—atherosclerosis	3.5e-05	0.000117	CbGpPWpGaD
Mepenzolate—CHRM3—Signaling Pathways—IL6—atherosclerosis	3.49e-05	0.000117	CbGpPWpGaD
Mepenzolate—CHRM2—Signaling Pathways—IL6—atherosclerosis	3.45e-05	0.000116	CbGpPWpGaD
Mepenzolate—CHRM1—Signaling Pathways—AKT1—atherosclerosis	3.23e-05	0.000108	CbGpPWpGaD
Mepenzolate—CHRM3—Signaling Pathways—AKT1—atherosclerosis	3.22e-05	0.000108	CbGpPWpGaD
Mepenzolate—CHRM2—Signaling Pathways—AKT1—atherosclerosis	3.19e-05	0.000107	CbGpPWpGaD
